Envoy Medical CEO Brent Lucas receives updated compensation: $420k salary, $105k bonus target, 1M options, 1M RSUs

Envoy Medical, Inc.

CEO Brent Lucas base salary raised to $420,000 per year, cash bonus targeted at $105,000 based on 2026-2027 strategic goals.
Committee approved issuance of 1,000,000 stock options at $0.634 per share, vesting over four years.
1,000,000 restricted stock units granted, vesting upon FDA approval of Acclaim cochlear implant (performance period through June 18, 2030).
RSU award is subject to Envoy Medical's 2023 Equity Incentive Plan and includes mandatory sale to cover withholding taxes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.